1. Optic pathway–hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature
- Author
-
Shalom Michowiz, Natalia Serova, Giuseppe Cinalli, Helen Toledano, Ulrich-W. Thomale, Ben Shofty, Jonathan Roth, Roger J. Packer, Kirsten van Baarsen, and Shlomi Constantini
- Subjects
Male ,Optic Nerve Glioma ,Pediatrics ,medicine.medical_specialty ,Optic glioma ,Astrocytoma ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,medicine ,Humans ,Neurofibromatosis ,Child ,Ganglioglioma ,Third ventricle ,Pilocytic astrocytoma ,Brain Neoplasms ,business.industry ,Incidence (epidemiology) ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,Hydrocephalus ,medicine.anatomical_structure ,Child, Preschool ,030220 oncology & carcinogenesis ,business ,Intracranial Hemorrhages ,030217 neurology & neurosurgery - Abstract
OBJECTIVEHemorrhage (also known as apoplexy) in optic pathway gliomas (OPGs) is rare. Because of the variable presentations and low incidence of OPG hemorrhages, little is known about their clinical course and the best treatment options. The aim of this work was to review risk factors, clinical course, and treatment strategies of optic glioma hemorrhages in the largest possible number of cases.METHODSA total of 34 patients were analyzed. Nine new cases were collected, and 25 were identified in the literature. Data regarding demographics, radiological and histological features, treatment, and outcome were retrospectively reviewed.RESULTSThe majority of patients were younger than 20 years. Only 3 patients were known to have neurofibromatosis. The histopathological diagnosis was pilocytic astrocytoma in the majority of cases. Five patients had intraorbital hemorrhages, whereas 29 patients had intracranial hemorrhage; the majority of intracranial bleeds were treated surgically. Six patients, all with intracranial hemorrhage, died due to recurrent bleeding, hydrocephalus, or surgical complications. No clear risk factors could be identified.CONCLUSIONSIntracerebral OPG hemorrhages have a fatal outcome in 20% of cases. Age, hormonal status, neurofibromatosis involvement, and histopathological diagnosis have been suggested as risk factors for hemorrhage, but this cannot be reliably established from the present series. The goals of surgery should be patient survival and prevention of further neurological and ophthalmological deterioration.
- Published
- 2018
- Full Text
- View/download PDF